Efficacy of levofloxacin-based triple therapy as a second-line therapy for H. pylori eradication after triple therapy failure

被引：0
|
作者：
Mahachai, Varocha [1 ,2 ]
Thongbai, Thirada [3 ]
Vilaichone, Ratha-Korn [2 ,4 ]
机构：
[1] Chulalongkorn Univ Hosp, Dept Med, Div Gastroenterol, Bangkok, Thailand
[2] Natl Gastr Canc & Helicobacter Pylori Res Ctr, Bangkok, Thailand
[3] Cent Hosp, Dept Med, Bangkok, Thailand
[4] Thammasat Univ Hosp, Dept Med, Gastroenterol Unit, Bangkok, Thailand
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2012年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [1] Efficacy of Levofloxacin-based Triple Therapy as a Second-line Therapy for H. pylori Eradication After Triple Therapy Failure
    Mahachai, Varocha
    Thongbai, Thirada
    Vilaichone, Ratha-korn
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S43 - S43
  • [2] Efficacy of levofloxacin-based triple therapy as a second-line therapy after triple therapy failure
    Mahachai, Varocha
    Chaithongrat, Supakarn Chaithongrat
    Vilaichone, Ratha-Korn
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 103 - 103
  • [3] EFFICACY OF LEVOFLOXACIN-BASED TRIPLE THERAPY AS A SECOND-LINE THERAPY AFTER TRIPLE THERAPY FAILURE
    Mahachai, V.
    Thongbai, T.
    Vilaichone, R.
    [J]. HELICOBACTER, 2012, 17 : 101 - 101
  • [4] Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy
    Watanabe, Y
    Aoyama, N
    Shirasaka, D
    Maekawa, S
    Kuroda, K
    Miki, I
    Kachi, M
    Fukuda, M
    Wambura, C
    Tamura, T
    Kasuga, M
    [J]. DIGESTIVE AND LIVER DISEASE, 2003, 35 (10) : 711 - 715
  • [5] Levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication:: Update
    Finizio, R
    Nista, EC
    Candelli, M
    Zocco, MA
    Ojetti, V
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. HELICOBACTER, 2005, 10 (05) : 528 - 528
  • [6] Levofloxacin based triple therapy as second-line treatment for H. pylori infection after failure of standard triple therapy.
    Festa, V
    Perri, F
    Boschetto, S
    Giovannone, M
    Tosoni, M
    Andriulli, A
    Barberani, F
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A587 - A587
  • [7] Levofloxacin-based triple therapy in second-line treatment for H-pylori eradication:: Update.
    Nista, EC
    Candelli, M
    Santoro, M
    Cazzato, IA
    Finizio, R
    Fini, L
    Ojetti, V
    Zocco, MA
    Gabrielli, M
    Santarelli, L
    D'antona, G
    Cammarota, G
    Gasbarrini, GB
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2005, 128 (04) : A63 - A63
  • [8] 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication
    Nista, EC
    Cazzato, IA
    Di Caro, S
    Candelli, M
    Ojetti, V
    Gabrielli, M
    Santarelli, L
    Nista, R
    Fini, L
    Cammarota, G
    Gasbarrini, G
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A359 - A359
  • [9] 10 days levofloxacin-based triple therapy in second-line treatment for Helicobacter pylori eradication
    Nista, EC
    Candelli, M
    Fini, L
    Cazzato, IA
    Finizio, R
    Lauritano, C
    Cammarota, G
    Martino, A
    Gasbarrini, G
    Gasbarrini, A
    [J]. GASTROENTEROLOGY, 2004, 126 (04) : A74 - A74
  • [10] Levofloxacin-based triple therapy versus bismuth-based quadruple therapy as a second line treatment for the eradication of H. pylori infection
    Karatapanis, S.
    Skorda, L.
    Georgopoulos, S.
    Papantoniou, N.
    Papastergiou, V.
    Ntoutsikos, K.
    Komnianides, K.
    Lisgos, Ph
    [J]. ANNALS OF GASTROENTEROLOGY, 2009, 22 (04): : 263 - 267
12345